183 related articles for article (PubMed ID: 29540336)
21. Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.
Cho YK; Choi MG; Bak YT; Rhee PL; Kim SG; Jung HY; Seol SY
Dig Dis Sci; 2012 Dec; 57(12):3189-94. PubMed ID: 22772870
[TBL] [Abstract][Full Text] [Related]
22. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
[TBL] [Abstract][Full Text] [Related]
23. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Placebo-Controlled
Sierra-Arango F; Castaño DM; Forero JD; Pérez-Riveros ED; Ardila Duarte G; Botero ML; Cárdenas A; De la Hoz-Valle J
Can J Gastroenterol Hepatol; 2019; 2019():3926051. PubMed ID: 31929980
[TBL] [Abstract][Full Text] [Related]
25. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Lauritsen K; Devière J; Bigard MA; Bayerdörffer E; Mózsik G; Murray F; Kristjánsdóttir S; Savarino V; Vetvik K; De Freitas D; Orive V; Rodrigo L; Fried M; Morris J; Schneider H; Eklund S; Larkö A;
Aliment Pharmacol Ther; 2003 Feb; 17(3):333-41. PubMed ID: 12562445
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study.
Labenz J; Armstrong D; Zetterstrand S; Eklund S; Leodolter A
Aliment Pharmacol Ther; 2009 Jun; 29(11):1165-71. PubMed ID: 19298581
[TBL] [Abstract][Full Text] [Related]
27. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
Raghunath AS; Green JR; Edwards SJ
Clin Ther; 2003 Jul; 25(7):2088-101. PubMed ID: 12946553
[TBL] [Abstract][Full Text] [Related]
28. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of esomeprazole for treatment of poorly controlled asthma.
; Mastronarde JG; Anthonisen NR; Castro M; Holbrook JT; Leone FT; Teague WG; Wise RA
N Engl J Med; 2009 Apr; 360(15):1487-99. PubMed ID: 19357404
[TBL] [Abstract][Full Text] [Related]
31. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
[TBL] [Abstract][Full Text] [Related]
32. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
[TBL] [Abstract][Full Text] [Related]
33. Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
Edwards SJ; Lind T; Lundell L
Aliment Pharmacol Ther; 2006 Sep; 24(5):743-50. PubMed ID: 16918878
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
[TBL] [Abstract][Full Text] [Related]
35. Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis.
Vakil N
Aliment Pharmacol Ther; 2003 Feb; 17 Suppl 1():21-3. PubMed ID: 12614303
[TBL] [Abstract][Full Text] [Related]
36. A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.
Kahrilas PJ; Dent J; Lauritsen K; Malfertheiner P; Denison H; Franzén S; Hasselgren G
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1385-91. PubMed ID: 17950677
[TBL] [Abstract][Full Text] [Related]
37. Clinical and endoscopic evaluation of gastroesophageal reflux disease in patients successfully treated with esomeprazole.
da Silva EP; Nader F; Quilici FA; Eisig JN; Zaterka S; Meneghelli U
Arq Gastroenterol; 2003; 40(4):262-7. PubMed ID: 15264050
[TBL] [Abstract][Full Text] [Related]
38. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
Orlando RC; Monyak JT; Silberg DG
Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
[TBL] [Abstract][Full Text] [Related]
39. Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study.
Labenz J; Armstrong D; Zetterstrand S; Eklund S; Leodolter A
Aliment Pharmacol Ther; 2009 May; 29(9):959-66. PubMed ID: 19222417
[TBL] [Abstract][Full Text] [Related]
40. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Johnson DA; Le Moigne A; Hugo V; Nagy P
Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]